Global Companion Diagnostics Market, By Application, Technology, and Geography - Trends, Analysis and Forecast till 2024

Global Companion Diagnostics Market, By Application, Technology, and Geography - Trends, Analysis and Forecast till 2024

Report Description
Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying genetic mutations and the health and treatment approach implications. In July 2016, the U.S. FDA released a draft guideline for development of a therapeutic product accompanying an IVD companion diagnostic. Companion diagnostics include Gleevec (imatinib mesylate) and BCR-ABL LDT and DAKO C-KIT PharmDx, Herceptin (trastuzumab) and DAKO Herceptest; and Nolvaldex (tamoxifen) and laboratory-developed estrogen receptor positive test.
Market Dynamics
Companion diagnostics are beneficial for pharmaceutical companies who face challenges with respect to high drug development cost, safety and outcome of clinical trials, and long product approval time. Companion diagnostics lowers development costs, improves time to market and enhances drug safety by enabling rapid identification of target biomarker and the most effective drug therapy. For patients, the technology provides better treatment outcomes and lower morbidity risk. Use of technologies such as PCR, immunohistochemistry, and gene sequencing has enabled accurate diagnosis and determination of targeted cancer therapy. As the CDx tests also aid in revealing the off-target effects of a drug along with identification of a molecular target, CDx have become and indispensable tool for oncologists.
Market Taxonomy
This report segments the global companion diagnostics market on the basis of application, technology, and geography. On the basis of application, the market is categorized into breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma, and others. On the basis of technology, the market is segmented into immunohistochemistry, real-time PCR, gene sequencing, Fluorescence in situ hybridization (FISH), and others. For comprehensive understanding of market dynamics, the global companion diagnostics market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Key features of the study:

  • This report provides in-depth analysis of the companion diagnostics and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global companion diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Inc., Agilent Technologies, Inc., Danaher Corporation, GE Healthcare, Qiagen N.V., Roche Diagnostics, Myriad Genetics, Inc., bioMérieux SA, Illumina, Inc. and Siemens Healthcare
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, technology upgrades, market expansion, and marketing tactics
  • The global companion diagnostics market report caters to various stakeholders in this industry, including investors, device manufacturers, distributors and suppliers for companion diagnostics, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the companion diagnostics market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
  • Global Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Global Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real-time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Global Companion Diagnostics Market, By Geography:
  • North America
  • U.S.
  • U.S. Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • U.S. Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Canada
  • Canada Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Canada Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Europe
  • U.K.
  • U.K. Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • U.K. Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Germany
  • Germany Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Germany Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Italy
  • Italy Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Italy Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • France
  • France Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • France Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Spain
  • Spain Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Spain Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Russia
  • Russia Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Russia Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Rest of Europe
  • Rest of Europe Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Rest of Europe Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Asia-Pacific
  • China
  • China Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • China Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • India
  • India Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • India Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Japan
  • Japan Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Japan Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • ASEAN
  • ASEAN Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • ASEAN Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Australia
  • Australia Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Australia Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • South Korea
  • South Korea Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • South Korea Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Rest of Asia Pacific (APAC)
  • Rest of Asia Pacific Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Rest of Asia Pacific Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Latin America
  • Brazil
  • Brazil Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Brazil Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Mexico
  • Mexico Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Mexico. Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Rest of Latin America
  • Rest of Latin America Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Rest of Latin America Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Middle East
  • GCC
  • GCC Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • GCC Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Israel
  • Israel Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Israel Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Rest of Middle East
  • Rest of Middle East Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Rest of Middle East Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Africa
  • North Africa
  • North Africa Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • North Africa Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Central Africa
  • Central Africa Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Central Africa Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • South Africa
  • South Africa Companion Diagnostics Market, By Application:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • South Africa Companion Diagnostics Market, By Technology:
  • Immunohistochemistry
  • Real Time PCR
  • Gene Sequencing
  • FISH
  • Others
  • Company Profiles
  • Abbott Laboratories, Inc. *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Future Plans
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • GE Healthcare
  • Qiagen N.V.
  • Roche Diagnostics
  • Myriad Genetics, Inc.
  • bioMérieux SA
  • Siemens Healthcare
  • Illumina, Inc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet By Application
Market Snippet By Technology
Market Snippet By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Supply Side Drivers
Demand Side Drivers
Economic Drivers
Restraints
Market Opportunities
Regulatory Scenario
Industry Trend
Epidemiology/Prevalence/Incidence
Merger and Acquisitions
New Product Approvals/Launch
Promotion and Marketing Initiatives
Cost Tier Down Analysis
4. Global Biopharmaceuticals and Biomedicine Market, By Application, 2014 - 2024 (US$ Million)
Introduction
Market Share Analysis, 2015 and 2024 (%)
Y-O-Y Growth Analysis, 2014 - 2024
Segment Trends
Breast Cancer
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
Lung Cancer
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
Colorectal Cancer
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
Gastric Cancer
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
Melanoma
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
5. Global Biopharmaceuticals and Biomedicine Market, By Technology, 2014 - 2024 (US$ Million)
Introduction
Market Share Analysis, 2015 and 2024 (%)
Y-O-Y Growth Analysis, 2014 - 2024
Segment Trends
Real-Time PCR
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
Gene Sequencing
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
FISH
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
6. Global Biopharmaceuticals and Biomedicine Market, By Regions, 2014 - 2024 (US$ Million)
Introduction
Market Share Analysis, By Region, 2015 and 2024 (%)
Y-O-Y Growth Analysis, For Regions, 2014 - 2024
North America
Market Share Analysis, By Country, 2015 and 2024 (%)
Y-O-Y Growth Analysis, By Country, 2014 - 2024
U.S.
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Canada
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Europe
Market Share Analysis, By Country, 2015 and 2024 (%)
Y-O-Y Growth Analysis, By Country, 2014 - 2024
U.K.
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Germany
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Italy
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
France
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Russia
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Rest of Europe
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Asia Pacific
Market Share Analysis, By Country, 2015 and 2024 (%)
Y-O-Y Growth Analysis, By Country, 2014 - 2024
China
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
India
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Japan
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
ASEAN
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Australia
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
South Korea
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Rest of Asia Pacific
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Latin America
Market Share Analysis, By Country, 2015 and 2024 (%)
Y-O-Y Growth Analysis, By Country, 2014 - 2024
Brazil
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Mexico
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Rest of Latin America
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Middle East
Market Share Analysis, By Country, 2015 and 2024 (%)
Y-O-Y Growth Analysis, By Country, 2014 - 2024
GCC Countries
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Israel
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Rest of Middle East
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Africa
Market Share Analysis, By Country, 2015 and 2024 (%)
Y-O-Y Growth Analysis, By Country, 2014 - 2024
Northern Africa
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
Central Africa
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
South Africa
Country Trends
Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
7. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Company Profiles
Abbott Laboratories, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Agilent Technologies, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Danaher Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
GE Healthcare
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Qiagen N.V.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Roche Diagnostics
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
bioMérieux SA
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Myriad Genetics, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Siemens Healthcare
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Illumina, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Analyst Views
8. Section
References
Research Methodology
About us and Sales Contact
*Browse 90 market data tables and 40 figures on "Biopharmaceuticals and Biomedicine Market - Global forecast to 2024”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook